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Abstract. Cutaneous leishmaniasis is endemic to South America where diagnosis is most commonly conducted via
microscopy. Patients with suspected leishmaniasis were referred for enrollment by the Ministry of Health (MoH) in Lima,
Iquitos, Puerto Maldonado, and several rural areas of Peru. A 43-question survey requesting age, gender, occupation,
characterization of the lesion(s), history of leishmaniasis, and insect-deterrent behaviors was administered. Polymerase
chain reaction (PCR) was conducted on lesionmaterials at the Naval Medical Research Unit No. 6 in Lima, and the results
were compared with those obtained by the MoH using microscopy. Factors associated with negative microscopy and
positive PCR results were identiﬁed using χ2 test, t-test, and multivariate logistic regression analyses. Negative mi-
croscopy with positive PCR occurred in 31% (123/403) of the 403 cases. After adjusting for confounders, binary multi-
variate logistic regression analyses revealed that negative microscopy with positive PCR was associated with patients
who were male (adjusted odds ration [OR] = 1.93 [1.06–3.53], P = 0.032), had previous leishmaniasis (adjusted OR = 2.93
[1.65–5.22], P < 0.0001), had larger lesions (adjusted OR = 1.02 [1.003–1.03], P = 0.016), and/or had a longer duration
between lesion appearance andPCR testing (adjustedOR=1.12 [1.02–1.22],P= 0.017). Future research should focus on
further exploration of these underlying variables, discovery of other factors that may be associated with negative mi-
croscopy diagnosis, and the development and implementation of improved testing in endemic regions.
INTRODUCTION
Leishmaniasis describes a disease caused by infectionwith
a protozoan parasite in the genus Leishmania, which can
manifest as three forms: cutaneous, mucocutaneous, and
visceral. Leishmaniasis is transmitted to the human host by
the bite of infected phlebotomine sand ﬂies of the genus
Lutzomyia in the New World and Phlebotomus in the Old
World.1–3 This disease is estimated to cause around 51,000
deaths worldwide each year, with global incidence rising
annually.4 Currently, themost common form of leishmaniasis
is cutaneous, with close to 1million reported cases in the past
5 years.5 Cutaneous leishmaniasis (CL) occurs in the Amer-
icas, the Mediterranean Basin, and western Asia (from the
MiddleEast toCentral Asia)with 70–75%of casesoccurring in
10 countries: Afghanistan, Algeria, Colombia, Brazil, Iran,
Syria, Ethiopia, North Sudan, Costa Rica, and Peru.6
In developing countries, routine diagnosis of all forms of
leishmaniasis often combines clinical symptoms with direct mi-
croscopic examination, serology, and culture. However, clinical
manifestations are often varied and symptoms can be sub-
clinical, whereas culturemethods are time-consuming andoften
produce no yield.7,8 All of these factors contribute to the low
sensitivity associated with these methods.9 On the other hand,
molecular methods, such as polymerase chain reaction (PCR),
are used primarily in research and approach 99–100% in both
sensitivity and speciﬁcity.10–15 Although direct visualization of
the parasite is the most commonly used technique and often
considered the gold standard of diagnosis for both visceral
leishmaniasis (VL) and CL, there is currently no consensus on
which method should be regularly used.16,17
In most rural clinical laboratories, microscopy is used for
routine diagnosis, creating an opportunity for inaccurate di-
agnoses, which can impact the patient and the health-care
system.8 False positivesmay lead tounnecessary therapieswith
potentially toxic drugs, whereas false negatives can result in
prolonged disease courses, increased resource utilization for
repeat testing,andgreaterpatientsuffering.18Forexample, it has
been established that reinfection and drug resistance can occur
if treatment of leishmaniasis is not appropriate or timely.19
Although studies have begun to explore risk factors asso-
ciated with false-negative PCR results in the diagnosis of
leishmaniasis, few data describe the risk factors for negative
microscopy/positive PCR results, especially in endemic set-
tings.20 This study seeks to elucidate any relationship be-
tween demographics, lesion characteristics, and/or insect
deterrent behaviors and negative microscopy/positive PCR
results. This information could prove vital in identifying indi-
viduals at risk for false-negative diagnosis, who could beneﬁt
from alternative diagnostic methods or further workup in
leishmaniasis-endemic areas where microscopy is routinely
used for diagnosis.
MATERIALS AND METHODS
Ethics. This study was approved by the Naval Medical
Research Unit No. 6 (NAMRU-6) Institutional Review Board.
Adult participants provided written informed consent and
participants aged 8–17 years provided written informed as-
sent. Parents of participants aged 5–17 years providedwritten
informed parental consent.
Study design. The parent study of this project was a cross-
sectional, sentinel surveillance study conducted from 2007 to
2015, which enrolled 485 patients aged 5–65 years at the
followingstudysites inPeru: Lima, Iquitos,PuertoMaldonado,
as well as other smaller and more remote locations (Figure 1).
* Address correspondence to Ryan Lamm, Thomas Jefferson Univer-
sity Hospital, 111 S. 11th St., Philadelphia, PA 19107. E-mail: ryan.
lamm@jefferson.edu
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Individuals who were identiﬁed with suspected or conﬁrmed
CLwere referred byMinistry of Health (MoH) staff to one of the
study sites. The study described here is a nested, case–
control study, using 403 eligible cases from the parent study.
Eighty-two cases from the parent study were deemed in-
eligible and eliminated from the present study because they
were identiﬁed in themilitary hospital in Lima and did not have
microscopy data to use in the analysis.
Inclusion/exclusion criteria. Inclusion criteria. The inclu-
sion criteria were as follows: 1) participant aged 5–65 years, 2)
laboratory-conﬁrmed case or clinical suspicion of CL (clinical
suspicion consisted of the presence of an erythematous
papule, nodule, plaque, ulcer, or scar at the site of a suspected
sand ﬂy bite, with or without raised and reddened lesion bor-
ders, ulcers that were large and painless, unless secondary
infection had occurred, and/or lesions associated with
lymphadenopathy), and 3) signed informed consent/assent.
Exclusion criteria. The exclusion criteria were as follows: 1)
currently under treatment of leishmaniasis or 2) had un-
dergone treatment of leishmaniasis in the past 6 months.
Specimen collection. After explaining the study proce-
dures, risks, and beneﬁts and obtaining informed consent/
assent, a trained MoH health-care worker and/or NAMRU-6
researcher collected the most appropriate clinical samples as
described in the following paragraphs. Preliminary diagnosis
was performed on-site by direct light microscopy examina-
tion. Further conﬁrmation of diagnosis and species via PCR
was performed by the NAMRU-6 in Lima. Different collection
methods were used to gather as much clinical data as pos-
sible. When applicable, all methods were used to obtain the
samples.
Filter paper sampling. After cleaning the affected skin area
with sterile gauze and alcohol, a 9-cm Fisher-brand, wet-
strengthened qualitative ﬁlter paper (Fisher Scientiﬁc, Pittsburgh,
PA) was gently pressed on the ulcer base. The ﬁlter paper was
allowed to air-dry. Then, 10-mm ﬁlter-paper puncheswere stored
in 1.5-mL microcentrifuge tubes containing 100% ethanol.
Lancet sampling.Acotton swabwith 70%ethanolwasused
to clean around the lesion border. Using a new, Goldenrod
animal lancet, exudate from the inner margin of the lesion
border was obtained.With this exudate, two slidesweremade
formicroscopy diagnosis on-site at the study locations. Using
a second, new lancet, more exudate from inside the border
region of the lesion was obtained and placed in a micro-
centrifuge tube (1.5 mL) containing 1mL of 70% ethanol. With
this exudate, additional two slides were made for an archive
and conﬁrmatory diagnosis at NAMRU-6, Lima.
Biopsy sampling. Local anesthetic (i.e., Xylocaine 5%) was
injected at the border of the clean lesion, and a 3.5–4 mm di-
ameter punch biopsy was obtained from the lesion border.
The biopsy sample was split into 2–3 parts, depending on the
size, and placed in 1.5mLmicrofuge tubes containing 1mL of
70% ethanol. All samples were stored for 1–2 weeks at re-
search sites before being transported to NAMRU-6 facilities
FIGURE 1. Map of lesion collection sites included in this study. This ﬁgure appears in color at www.ajtmh.org.
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in Lima. Aliquots from these specimens were used for DNA
isolation and PCR analysis for leishmaniasis diagnosis.
Patient questionnaire. A 43-item questionnaire was ad-
ministered to each consenting study participant or their legal
guardian to obtain information regarding age, gender, occu-
pation, location, and characterization of the lesion(s), history
of leishmaniasis, insect-deterrent behaviors, and other fac-
tors (Supplemental Questionnaire).
Data analysis. Polymerase chain reaction analysis target-
ing kDNA was conducted on lesion materials obtained from
ﬁlter paper samples, lancet-extracted exudate, and punch
biopsies following protocols described in the literature.21 If a
positive PCR result was obtained from one or more of the
specimens collected from a patient, then he/she was con-
sidered positive by PCR. Based on the questionnaire, a pre-
liminary analysis of 131 cases from the research sites inMadre
de Dios was performed. Risk factors found to be associated
with negative microscopy/positive PCR via χ2 test and t-tests
during the initial analysis were included in the present
study’s investigation. The included risk factorswere examined
using cross-tabular analyses with χ2 of independence when
data were categorical and independent two-sample t-tests
when data were continuous (nonparametric tests were
also conducted on these data, and ﬁndings were identical).
The factors included in the present analysis were age, gen-
der, occupation, number of lesions, diameter of the lesion,
previous leishmaniasis, time from appearance of the lesion
to PCR-based diagnosis, presence of concurrent mucosal
leishmaniasis, presence of superimposed bacterial infection
of the lesion, and whether the patient’s residence had been
fumigated within the last 6 months.
Of note, for the analysis of occupation, categories included
agricultural workers/wood extractors and gold extractors
(both classiﬁed as high-exposure-to-sand ﬂy groups because
they work outdoors), students (low-exposure group), and
others. The agricultural worker/wood extractor occupation
group was chosen as the reference group based on the hy-
pothesis that this group likely had the highest exposure to
sand ﬂies because workers in these occupations directly en-
croach on forested sand ﬂy habitats.19
Binarymultivariate logistic regressionmodelingwasused to
estimate the adjusted odds of a false-negative microscopy
reading for identiﬁed risk factors, with 95% conﬁdence inter-
vals also being calculated. By convention, all tests of signiﬁ-
cance were two-tailed and evaluated at the level of P < 0.05.
Data analyses were conducted using SAS 9.3 (SAS Institute
Inc., Cary, NC).
Eighty-twocaseswerenoteligible for thestudybecause these
patients presented to Hospital Militar Central in Lima and mi-
croscopy data were not readily available to use in the analysis.
Cross-tabular analyses with χ2 test of independence and in-
dependent two-sample t-testswere also conducted to elucidate
any differences between the eligible and ineligible groups.
RESULTS
Among the 485 individuals in the parent study who tested
positive for leishmaniasis by PCR, microscopy was not per-
formed on the 82 participants who were excluded from the
nested, case–control study. Demographic, location of enroll-
ment, and occupation data were collected and recorded
(Table 1). Of the 403 eligible individuals with PCR positive
diagnosis, microscopy yielded 123 negative and 280 positive
results. Using the PCR-obtained results for comparison, mi-
croscopy was 56% (157/280) sensitive and 94% (116/123)
speciﬁc for diagnosing leishmaniasis (Table 2).
Patients with negative microscopy/positive PCR results
were ﬁrst compared with patients with all other results using
χ2 test and t-tests. Patientswith negativemicroscopy/positive
PCR were more likely to have larger lesion diameters (24.7
versus 19.9 mm, P = 0.010), multiple lesions (40% versus
28%, P = 0.036), previous history of leishmaniasis (46.2%
versus 26.8%, P = 0.001), and longer duration between lesion
appearance and PCR testing (2.90 versus 2.07 months, P =
0.003). Finally, negative microscopy/positive PCR tended to
occur in younger patients (27.0 versus 29.9 years, P = 0.069),
although this difference was not statistically signiﬁcant
(Table 3). Negative microscopy/positive PCR results were not
signiﬁcantly associated with gender, occupation, concurrent
mucosal leishmaniasis, concurrent bacterial infection of the
lesion, or fumigation of the participant’s residence in the
preceding 6 months.
Binary multivariate logistic regression analyses demon-
strated that male patients were almost twice as likely to have
negative microscopy/positive PCR (adjusted OR = 1.93
[1.06–3.53], P = 0.032), patients who had previous leishman-
iasis were around three times as likely (adjusted OR = 2.93
[1.65–5.22], P < 0.0001), and patients who had larger lesions
(adjusted OR = 1.02 [1.003–1.03], P = 0.016) and/or had a
longer duration between lesion appearance and PCR testing
(adjusted OR = 1.12 [1.02–1.22], P = 0.017) were also at in-
creased risk for negative microscopy/positive PCR results
(Table 4). Again younger age was seen as marginally statisti-
cally related to higher negativemicroscopy/positivePCR rates
(adjusted OR = 0.98 [0.96–1.002] P = 0.07). Factors that were
TABLE 1
Demographic, location of enrollment, and occupation information for
the 403 cases included in the study
Demographic information Total
Age (years)
³ 60 17
50–59 18
40–49 41
30–39 79
20–29 136
10–19 91
0–9 18
N/A 3
Gender
Male 317
Female 86
Location of enrollment
Hospital Militar Central, Lima 2
Hospital Iquitos, Iquitos 55
Puerto Maldonado (Centro de Salud Jorge Chavez,
Hospital Santa Rosa, Centro de Salud Nuevo Millenio,
Laboratorio Referencial, Hospital Tambopata, Puesto
de Salud Flor de Acre), Madre de Dios
258
Delta 1, Madre de Dios 74
Hospital Iberia, Madre de Dios 13
Puesto de Salud Otilin, Madre de Dios 1
Occupation
Agriculture/wood extraction 87
Gold extraction 59
Student 96
Other 161
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not signiﬁcantly associated after adjustment included occu-
pation, number of leishmaniasis lesions, concurrent mucosal
leishmaniasis, concurrent bacterial infection of the lesion, and
fumigation of the participant’s residence in the preceding
6 months.
Finally, analyses performed on the 82 ineligible cases found
that compared with the 403 cases eligible for this study, a
higher proportionweremale, identiﬁedas students or other for
their occupation, and had a concurrent bacterial infection.
Besidesgender, therewerenosigniﬁcant differencesbetween
those eligible and ineligible regarding any of the variables that
were found to be associated with negative microscopy/
positive PCR results in this study.
DISCUSSION
Our study found that compared with PCR results, micros-
copy has a sensitivity of 56% in the diagnosis of leishmaniasis.
Leishmaniasis diagnosis is largely based on clinical criteria with
microscopy and visualization being the most commonly used
methodofdiagnostic detection in rural areas.8Complicating the
situation is the variability of clinical manifestations of leish-
maniasis, rendering clinical diagnosis difﬁcult.22 In addition,
patients in theseareasoftenneedapositivediagnosis to receive
aid topay for treatment.Given theseconsiderations, anyﬂaws in
the diagnostic method are worthy of exploration, especially
because undiagnosed and untreated leishmaniasis can be a
disﬁguring disease, advance to afﬂict mucosal surfaces and
visceral organs, and ultimately become fatal (in the case of
visceral disease).23
This study also identiﬁed statistically signiﬁcant factors that
placed patients at an increased risk of receiving negative
microscopy/positive PCR results. Whereas certain factors,
such asmale gender, may be intuitive because of the fact that
malesmore frequently are used outside and at risk for sand ﬂy
bite, other factors identiﬁed may not. The reasons these se-
lected factors may predispose patients to negative readings
maybeexplained by reviewingmicroscopic technique and the
immune response to leishmaniasis infection.
To receive a positive diagnosis of leishmaniasis via mi-
croscopy, visualization of amastigotes must be achieved.
However, failure to do so can simply imply low parasite load,
rather than an absence of parasites altogether.24 Sand ﬂy
saliva upregulates various aspects of the immune response,
including complement activation, T-cell proliferation, hema-
topoiesis, and the activity of antigen-presenting cells.25 This
immune response begins to decrease parasitic load, meaning
chronic leishmaniasis infections demonstrate lower parasitic
loads than acute infections.26
In addition, the host immune response creates the oppor-
tunity for acquired immunological resistance to develop in
patients previously infected.27 Therefore, when patients be-
come reinfected, the immune response is augmented, leading
to decreased parasitic load.28 Moreover, multiple lesions are
the result of spread or relapse of the primary infection, or a
concurrent secondary leishmaniasis infection.24 Both of these
scenarios involve a primary immunologic response followed
by either continuation or reactivation of that response which,
as explained previously, leads to decreased parasitic load.
Low parasitic load is also a result of duration of time, in which
the immune system clears the lesion of amastigotes, resulting
in negativemicroscopy readings the longer thepatientwaits to
be tested.13,29 This evidence could explain our observation
that longer duration between lesion appearance and PCR
testing, previous leishmaniasis exposure, andmultiple lesions
predispose patients to negative microscopy readings.
Another explanation for a low parasitic yield, and sub-
sequent negative microscopy reading, involves acquisition of
the lesion material. The World Health Organization guidelines
recommend that exudative material be taken from the lesion
border, where parasitic load is believed to be higher.30 Al-
though this technique is widely used in ﬁeld sites, more recent
studies have shown that median parasite loads are signiﬁ-
cantly higher in the lesion base and center than in the lesion
border.31,32 This discrepancy could lead to a decreased par-
asitic yield becausemost practitioners target the lesion border
for sample collection. This effect could be exacerbated as
distance from the lesion center increases, meaning that a
larger distancebetween the center of the lesion and theborder
could result in an even smaller parasitic yield. This could
TABLE 2
Results of microscopy and PCR analysis for the 403 cases included in
this study
PCR results
Total+ −
Microscopy results + 157 7 164
− 123 116 239
Total 280 123 403
PCR = polymerase chain reaction.
TABLE 3
Patient demographics, lesion characteristics, and proposed risk fac-
tors for participants with negative microscopy/positive PCR as
compared with patients with all other results
False
negative
(N = 123)
Other
(N = 280) P value
Age in years, mean (SD) 27.0 (13.3) 29.9 (14.8) 0.069
Gender
Male, no. (%) 91 (28.7) 226 (71.3) 0.129
Female, no. (%) 32 (37.2) 54 (62.8)
Occupation
Agriculture/wood extraction,
no. (%)
28 (32.2) 59 (67.8) 0.402
Gold extraction, no. (%) 15 (25.4) 44 (74.6)
Student, no. (%) 35 (36.5) 61 (63.5)
Others, no. (%) 45 (28) 116 (72)
Number of lesions
One, no. (%) 86 (28) 221 (72) 0.036
Two or more, no. (%) 36 (39.6) 55 (60.4)
Diameter of lesion in mm, mean (SD) 24.7 (19.7) 19.9 (15.2) 0.01
Previous leishmaniasis?
Yes, no. (%) 36 (46.2) 42 (53.8) 0.001
No, no. (%) 87 (26.8) 238 (73.2)
Duration from lesion appearance to
PCR testing in months, mean (SD)
2.90 (3.05) 2.07 (2.37) 0.003
Concurrent mucosal leishmaniasis?
Yes, no. (%) 12 (35.3) 22 (64.7) 0.528
No, no. (%) 111 (30.1) 258 (69.9)
Concurrent bacterial infection?
Yes, no. (%) 64 (32.5) 133 (67.5) 0.402
No, no. (%) 59 (28.6) 147 (71.4)
Residence fumigated in past 6
months?
Yes, no. (%) 54 (29.8) 127 (70.2) 0.939
No, no. (%) 64 (30.2) 148 (69.8)
No. = number; PCR = polymerase chain reaction; SD = standard deviation. For categorical
data, cross-tabular analyseswith χ2 test of independencewere used and for continuous data,
independent two-sample t tests were used.
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explain our observation that larger lesionspredisposepatients
to negative microscopy results.
The ﬁnding that is perhaps most difﬁcult to explain is the
marginal inverse relationship between age and negative mi-
croscopy readings. As per the explanations given previously,
one would expect that younger patients would be leishmani-
asis naive and, thus, their immune response would be di-
minished, resulting in an increasedparasitic load.However, an
alternative explanation that could help explain our contradic-
tory observation is that because adult patients are the most
commonly affected population, lesions that are present in
children are largely ignored ormisdiagnosed. Thus, when they
are ﬁnally tested, the infection could be more chronic than in
adult patients.28
One ﬁnal hypothesis that may help explain our ﬁndings is
that patients with large lesions, multiple lesions, and/or who
have had the lesion for an extended period of time are more
likely to have used topical substances, which has been shown
to lower the sensitivity of microscopy readings.9
The high prevalence of negative microscopy/positive PCR
readings in the diagnosis of CL demands the development
of high-sensitivity, low-cost, and ﬁeld-deployable diagnos-
tic tests. Currently, there are very few alternatives for CL
diagnosis under development, such as direct boil loop-
mediated isothermal ampliﬁcation (LAMP).33 By contrast, a
wide set of diagnostic tools have been developed for the de-
tectionof VL, such as rapid detection tests for theK3934,35 and
K2836 genes as well as LAMP tests.37 It has been shown that
even though all these methods are feasible in the diagnostic
detection of VL, their use in the diagnosis of CL is equivocal or
of no use.38
The most common types of leishmaniasis in the areas in-
cluded in this study are those caused by Leishmania ama-
zonensis, braziliensis, mexicana, peruviana, panamensis, and
guyanensis, which most frequently manifest as CL.37,39 This
collection of infections, also known as New World CL, is
similar in countries throughout the West and East Andes;
therefore, the results of our study are largely generalizable to
these regions. In addition, our results are relevant in areas
afﬂicted with Old World CL, such as some areas of Africa
and theMiddle East.40 However, our present studymay not be
generalizable to areas in which the species that cause VL,
diffuse, and/or mucosal leishmaniasis are predominant.
Nonetheless, it is worth noting that even in these areas,
leishmaniasis often begins as a cutaneous infection.8
We would like to acknowledge the possibility of measure-
ment bias due to the fact that when sampling was subjected
to PCR analysis, it was performed so using a combination of
samples from all methods of collection (i.e., ﬁlter paper, lancet
sampling, and/or punch biopsy). Lesions were called positive
for leishmaniasis when one of the PCR results from the ma-
terial collected was positive. However, individual results for
each type of material were not recorded. Therefore, no con-
clusions can be made regarding the sensitivity and speciﬁcity
of each individual collection method from this study.
In addition, as in most endemic areas, at each of the study
sites, different personnel were responsible for obtaining lesion
exudate andmaking the primary diagnosis for the patients. This
occurred before members of this research protocol collected
samples used for our analysis and may have introduced some
uncontrolled variability, as those making the initial diagnosis
couldhavehadvaryingdegreesof technical skills anddiagnostic
experience. A limitation of this study is our inability to control for
variability among personnel making the initial diagnosis. Be-
cause of the low number of samples from certain sites in the
study,wewere unable toobtain reliable statistical comparisonof
onesite’spersonnel’saccuracy indiagnosisversusanother.One
suggestion for future studies would be to send known leish-
maniasispositiveandnegativemicroscopicsamples toeachsite
to serve as a control for diagnostic accuracy.
Finally, we do not believe that the 82 excluded cases
compromised the generalizability of our results. These patients
were military individuals enrolled in a survival course at sites in
El Alamo and Alto Amazonas in Peru. During the time of their
infection, as part of the military training, the military personnel
were purposely exposed to extremely poor sanitary condi-
tions.41 These conditions would be abnormal for the average
rural citizen exposed to leishmaniasis and, thus, the inclusion
of these samples would likely jeopardize the generalizability of
our ﬁndings. If these individuals had contracted the disease
while on military duty, not during an artiﬁcially created environ-
ment, they certainly would have been included in the analysis.
In conclusion, there exists a need for the development
and implementation of high-sensitivity, low-cost CL diagnostic
tests, especially in resource-poor settings. In the meantime,
certain measures, including highly qualiﬁed and trained profes-
sionals collecting samples, standardized diagnostic protocols,
and uniformity of clinical criteria, should be implemented to
minimize the incidence of false-negative diagnoses. Another
potential outcome of this study may involve preemptive re-
ferral of patients with risk factors for false-negative di-
agnoses to facilities that can perform more sensitive
diagnostic tests (e.g., PCR) to prevent detrimental delays in
diagnosis and treatment. In addition, closer and increased
patient follow-up should continue to contribute to ongoing
surveillance of the accuracy of the available diagnostic tests.
These processes are vital in not only preventing more pa-
tients from receiving incorrect diagnoses and not receiving
the treatment they require but also in tracking the distribution
of Leishmania parasites and vector populations, which may
be rapidly evolving because of climate change and other
factors.42
TABLE 4
Adjusted odds ratios for risk factors associated with increased neg-
ative microscopy/positive PCR results
Risk factor OR 95% CI P value
Age (years) 0.981 0.96–1.002 0.071
Gender (male) 1.931 1.056–3.528 0.032
Occupation
Agriculture/wood extraction Reference occupation
Gold extraction 0.905 0.392–2.091 0.816
Student 1.015 0.465–2.215 0.971
Other 0.665 0.349–1.267 0.215
Diameter of lesion 1.017 1.003–1.031 0.016
Duration from lesion appearance
to PCR testing
1.116 1.020–1.221 0.017
Number of lesions (more than one) 1.545 0.894–2.672 0.119
Previous leishmaniasis (yes) 2.934 1.647–5.224 < 0.0001
Concurrentmucosal leishmaniasis
(yes)
1.039 0.437–2.474 0.93
Concurrent bacterial infection
(yes)
1.158 0.711–1.886 0.555
House fumigated in past 6 months
(yes)
0.902 0.548–1.486 0.686
CI = conﬁdence interval; PCR = polymerase chain reaction.
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